ENTITY
Novo Nordisk

Novo Nordisk (NOVOB DC)

87
Analysis
Health Care • Denmark
Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.
more
bullish•Cross Asset Strategy
•23 May 2024 08:22

Taiwan Shines as China & Japan Decline:  Global Funds Top-Down Positioning Report

Taiwan allocations rise in face of subdued Asia.  USA dominant though Value funds increase underweights.  UK, France & Netherlands remain key...

Logo
533 Views
Share
bullish•Tencent
•04 May 2024 00:35

Upgrading Emerging Markets to Market Weight; China/Hong Kong Continue to Bottom; Energy Breakdowns

Upgrading Emerging Markets $EEM $VWO to Market Weight; China/Hong Kong Continue to Bottom $FXI $MCHI $KWEB; Lows Likely in on $ACWI; Commodities...

Logo
696 Views
Share
•27 Feb 2024 21:09•Syndicated

Europe's Magnificent Eleven

The GRANOLAS Dubbed the “Granolas” by Goldman Sachs in 2020, this basket was chosen because it echoed themes present amongst the Mag 7 (back then...

Logo
422 Views
Share
bullish•iShares MSCI ACWI ETF
•20 Jan 2024 04:58

Pause/Pullback Underway; Downgrading Europe and Mexico; Buys in Services, Tech, Comm, Healthcare

Pause/pullback underway in $ACWI, but as long as the $DXY remains below $106, the 10-year Treasury yield remains below 4.35%, and $ACWI is above...

Logo
637 Views
Share
•30 Sep 2023 00:05

Supports Starting to Break; Upgrading Non-U.S. Small-Caps to Overweight; Transports/Comm/HC Buys

Support levels on global indexes (EURO STOXX 50, $ACWX, $EFA) beginning to break as $DXY and 10-year Treasury yield $TNX break above $105.70 and...

Logo
698 Views
Share
x